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Abstract A diverse library of 34 new quaternary mono-
ammonium and bis-ammonium pyridoxine derivatives was
synthesized, and their antibacterial activity against several
clinically relevant bacterial strains was evaluated in vitro.
Several mono-ammonium compounds demonstrated high
antibacterial activity against methicillin-resistant Staphylo-
coccus strains with minimum inhibitory concentrations in
the range of 0.5–8 µg/mL, which exceeded activity of mir-
amistin and was comparable to that of benzalkonium
chloride. SOS-chromotest in Salmonella typhimurium
showed the lack of DNA-damage activity for all active
compounds. A clear correlation has been observed between
the lipophilicity of the obtained compounds and their
activity against the studied Gram-positive bacterial strains.
Cytotoxicity studies on HEK-293 cells demonstrated that
some of the active compounds were less toxic than the
reference drugs. Antibacterial activity studies in the pre-
sence of CaCl2 suggested that the cell wall damage asso-
ciated with the removal of Ca2+ ions from the bacterial
membrane is one of the possible mechanisms of anti-
bacterial activity. The obtained results make the described
active compounds a promising starting point for the
development of new antibacterial therapies.
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Introduction
Growing antibiotic resistance has become a major health
problem in recent decades and has encouraged many
researchers to search for novel antibacterial drugs. In par-
ticular, methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant enterococci and multidrug-
resistant Pseudomonas aeruginosa are associated with
increased rates of illness and death (Nordmann et al. 2007).
Since the 1930s, quaternary ammonium compounds (QACs)
are widely used for the control of bacterial growth in clinical
and industrial environments. Broad-spectrum antimicrobial and
antifungal activity (Krátký and Vinšová 2013; Oblak et al.
2013; Massi et al. 2003; Ohkura et al. 2003) and surfactant
properties have made QACs such as benzalkonium chloride
(Domagk 1935), ﬂuomizin (Tischer et al. 2012), miramistin and
cetylpyridinium chloride (Fromm-Dornieden et al. 2015) the
favored hygienic adjuncts in disinfectant cleansing formulations,
and they have also been increasingly deployed in therapy of
patients with local pyoinﬂammatory processes.
According to literature data (Tischer et al. 2012), QACs
generally act by disrupting the cytoplasmic and outer mem-
brane lipid bilayers through association of the positively
charged quaternary nitrogen with the anionic head groups of
acidic phospholipids and interaction of the lipophilic tail with
the hydrophobic membrane core. As a result, QACs form
mixed-micelle aggregates with hydrophobic membrane com-
ponents that solubilize membrane and lyse the cells. Bacterial
cell lethality occurs through generalized and progressive
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